CurrentRheuma
Get Weekly

Topic · page 18 of 20

Vasculitis & polymyalgia rheumatica

Giant cell arteritis, Takayasu arteritis and polymyalgia rheumatica; ANCA-associated vasculitis (granulomatosis with polyangiitis, microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis), polyarteritis nodosa, IgA vasculitis in adults, Behçet's disease, cryoglobulinemic and other vasculitis

Briefs 681–720 of 782 placed here, newest publication first

Briefs in Vasculitis & polymyalgia rheumatica

Newest publication first

  1. Rheumatology (Oxford)

    CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendum

    Guideline or statement

  2. Lancet Rheumatol

    Glucocorticoid Toxicity Index scores by domain in patients with antineutrophil cytoplasmic antibody-associated vasculitis treated with avacopan versus standard prednisone taper: post-hoc analysis of data from the ADVOCATE trial

    Secondary analysis

  3. Rheumatology (Oxford)

    Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production

    Mechanistic study

  4. Semin Arthritis Rheum

    Impact of previous glucocorticoid therapy on diagnostic accuracy of [18F] FDG PET-CT in giant cell arteritis

    Cohort study

  5. Ann Rheum Dis

    What is a response in randomised controlled trials in giant cell arteritis?

    Research article

  6. Ann Rheum Dis

    Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing

    Meta-analysis

  7. Clin Exp Rheumatol

    The epidemiology of pathologically confirmed clinically isolated aortitis: a North American population-based study

    Cohort study

  8. Clin Exp Rheumatol

    A Canadian vasculitis patient-driven survey to highlight which prednisone-related side effects matter the most

    Cross-sectional study

  9. Rheumatology (Oxford)

    Clinico-radiological correlation and prognostic value of baseline chest computed tomography in eosinophilic granulomatosis with polyangiitis

    Cohort study

  10. Arthritis Res Ther

    Ultrasound halo count in the differential diagnosis of atherosclerosis and large vessel giant cell arteritis

    Diagnostic or prognostic study

  11. Semin Arthritis Rheum

    Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study

    Cohort study

  12. Joint Bone Spine

    Traditional and disease-related cardiovascular risk factors in ANCA-associated vasculitis: A prospective, two-centre cohort study

    Cohort study

  13. Semin Arthritis Rheum

    Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases

    Cohort study

  14. Semin Arthritis Rheum

    Prognostic factors in giant cell arteritis associated aortitis with PET/CT and CT angiography at diagnosis

    Cohort study

  15. Rheumatology (Oxford)

    PET vascular activity score for predicting new angiographic lesions in patients with Takayasu arteritis: a Chinese cohort study

    Cohort study

  16. Ann Rheum Dis

    Risk factors for serious infections in ANCA-associated vasculitis

    Secondary analysis

  17. Arthritis Rheumatol

    The Effects of Daily Prednisone and Tocilizumab on Hemoglobin A 1c During the Treatment of Giant Cell Arteritis

    Secondary analysis

  18. Rheumatology (Oxford)

    Quality standards for the care of people with giant cell arteritis in secondary care

    Guideline or statement

  19. Rheumatology (Oxford)

    Ultrasonography in the assessment of disease activity in cranial and large-vessel giant cell arteritis: a prospective follow-up study

    Cohort study

  20. Rheumatology (Oxford)

    Mitochondrial DNA: a novel indicator of active inflammation in ANCA-associated vasculitides

    Cross-sectional study

  21. J Rheumatol

    Validation of the Antineutrophil Cytoplasmic Antibody Renal Risk Score and Modification of the Score in a Chinese Cohort With a Majority of Myeloperoxidase-Positive Patients

    Cohort study

  22. J Rheumatol

    Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multinational Retrospective Study

    Cohort study

  23. Arthritis Res Ther

    Predictors for pulmonary artery involvement in Takayasu arteritis and its cluster analysis

    Cohort study

  24. RMD Open

    Long delay from symptom onset to first consultation contributes to permanent vision loss in patients with giant cell arteritis: a cohort study

    Cohort study

  25. Arthritis Rheumatol

    Proteomics Landscape Mapping of Organ‐Resolved Behçet's Disease Using In‐Depth Plasma Proteomics for Identifying Hyaluronic Binding Protein 2 Expression Associated With Vascular Involvement

    Case-control study

  26. Semin Arthritis Rheum

    Efficacy and safety of leflunomide in the management of large vessel vasculitis: A systematic review and metaanalysis of cohort studies

    Meta-analysis

  27. RMD Open

    Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort

    Cohort study

  28. Arthritis Res Ther

    Integrative metabolomics of plasma and PBMCs identifies distinctive metabolic signatures in Behçet’s disease

    Case-control study

  29. Arthritis Care Res (Hoboken)

    Longitudinal Characterization of Vascular Inflammation and Disease Activity in Takayasu Arteritis and Giant Cell Arteritis: A Single‐Center Prospective Study

    Cohort study

  30. Arthritis Res Ther

    Distinct gene signatures of monocytes and B cells in patients with giant cell arteritis: a longitudinal transcriptome analysis

    Mechanistic study

  31. Clin Exp Rheumatol

    ANCA-associated pulmonary-renal syndrome treated with cyclophosphamide, rituximab, repeated methyl-prednisolone pulses and a reduced oral glucocorticoid regime: an observational study

    Cohort study

  32. Rheumatology (Oxford)

    Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study

    Cohort study

  33. Rheumatology (Oxford)

    Immune complex-mediated neutrophil activation in patients with polymyalgia rheumatica

    Mechanistic study

  34. Arthritis Care Res (Hoboken)

    Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual

    Cohort study

  35. J Rheumatol

    Lower Frequency of Comorbidities Prior to Onset of Giant Cell Arteritis: A Population-Based Study

    Case-control study

  36. Semin Arthritis Rheum

    Is there a role for Pneumocystis jiroveci pneumonia prophylaxis in giant cell arteritis or polymyalgia rheumatica?

    Meta-analysis

  37. Semin Arthritis Rheum

    Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients

    Cohort study

  38. Arthritis Rheumatol

    Alterations of Gut Microbiome, Metabolome, and Lipidome in Takayasu Arteritis

    Case-control study

  39. Ann Rheum Dis

    The provisional OMERACT ultrasonography score for giant cell arteritis

    Diagnostic or prognostic study

  40. Clin Exp Rheumatol

    Soluble Tyro-3 and Axl may reflect the current activity and the renal involvement in patients with microscopic polyangiitis and granulomatosis with polyangiitis

    Cohort study

All 782 Briefs in ExploreShowing Briefs 681–720 of 782, newest first